Africa CDC approves first locally manufactured PCR test for mpox made in Morocco

The Africa Centres for Disease Control and Prevention (Africa CDC) has approved the first locally manufactured PCR test for mpox, marking a significant step toward strengthening Africa’s public health self-sufficiency. 

Produced by Morocco-based Moldiag, the test kit met rigorous standards set by Africa CDC’s Diagnostic Advisory Committee (DAC), which includes input from 15 African health experts, according to Bloomberg.

This achievement aligns with the African Union's strategy to enhance epidemic preparedness and reduce reliance on external support during health emergencies.

“We believe that strengthening local production is key to empowering the continent in its epidemic preparedness and response, allowing us to respond rapidly and effectively to public health challenges,” said Moldiag’s CEO Nawal Chraibi, in a press release. 

Mpox, previously spreading undetected in Africa for years, was declared a global health emergency by the World Health Organization in August. While wealthier nations mobilized vaccines from stockpiles, African nations faced limited supplies, underscoring the urgent need for self-reliance in diagnostics and response efforts.

The mpox death toll in Africa surpassed 1,100 in mid-October, with most cases concentrated in the Democratic Republic of the Congo and Burundi. Africa CDC highlights cross-border transmission as a pressing issue, emphasizing the need for rapid detection and intervention.